Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.36 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14245092 | 0.87 | GABBR2 (0.32) | GABBR2GABBR1HIF1ACYP1A2CYP2D6 | |
| SCHEMBL1977392 | 0.85 | RXRB (0.34) | GABBR2GABBR1ALDH1A1HPGDTDP1 | |
| SCHEMBL1781629 | 0.82 | DRD1 (0.53) | — | |
| SCHEMBL811190 | 0.81 | POLB (0.39) | GABBR2GABBR1GABRA1GABRB2 | |
| SCHEMBL7566867 | 0.81 | CYP1A2 (0.34) | GABBR2GABBR1HIF1ACYP1A2CYP2D6 | |
| SCHEMBL21752859 | 0.79 | ALDH1A1 (0.31) | ALDH1A1HPGD | |
| SCHEMBL14612293 | 0.78 | GABBR2 (0.39) | GABBR2GABBR1GABRA1GABRB2 | |
| SCHEMBL21327677 | 0.78 | POLB (0.36) | GABBR2GABBR1ALDH1A1RECQLGABRA1 | |
| SCHEMBL2142578 | 0.78 | GABBR2 (0.36) | GABBR2GABBR1GABRA1GABRB2 | |
| SCHEMBL547487 | 0.78 | ALDH1A1 (0.39) | GABBR2GABBR1CYP1A2CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071578-B | P-chiral phosphine ligand and application thereof in asymmetric synthesis | 巴斯夫欧洲公司 | 2022-01-14 | — | — | CN | disclosed |
| US-11214636-B2 | Rigid non-cyclopentadienyl group 4 transition metal and rare earth metal catalysts for olefin polymerization | MCMASTER UNIVERSITY (CA) | 2022-01-04 | — | — | US | disclosed |
| EP-3904361-A2 | BORON CONTAINING COMPOUNDS | Merck Patent GmbH (DE) | 2021-11-03 | — | — | EP | disclosed |
| EP-3052505-B1 | BORON-CONTAINING COMPOUNDS | MERCK PATENT GMBH (DE) | 2021-06-23 | — | — | EP | disclosed |
| US-10919921-B2 | P-chiral phosphine ligands and use thereof for asymmetric synthesis | BASF SE | 2021-02-16 | — | — | US | disclosed |
| US-20200308322-A1 | RIGID NON-CYCLOPENTADIENYL GROUP 4 TRANSITION METAL AND RARE EARTH METAL CATALYSTS FOR OLEFIN POLYMERIZATION | MCMASTER UNIVERSITY (CA) | 2020-10-01 | — | — | US | disclosed |
| WO-2020040329-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 대구대학교 산학협력단 | 2020-02-27 | — | — | WO | disclosed |
| WO-2020040329-A1 | THERMALLY ACTIVATED DELAYED FLUORESCENT COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 대구대학교 산학협력단 | 2020-02-27 | — | — | WO | disclosed |
| US-20190211040-A1 | P-CHIRAL PHOSPHINE LIGANDS AND USE THEREOF FOR ASYMMETRIC SYNTHESIS | BASF SE (DE) | 2019-07-11 | — | — | US | disclosed |
| US-10224493-B2 | Boron-containing compounds | MERCK PATENT GMBH (DE) | 2019-03-05 | — | — | US | disclosed |
| WO-2006075177-A1 | PROCESS FOR THE MANUFACTURE OF SUBSTITUTED PROPIONIC ACIDS | PHOENIX CHEMICALS LTD. (GB) | 2006-07-20 | — | — | WO | disclosed |
| EP-1089818-B1 | CATALYST COMPRISING A COMPLEX OF A METAL OF GROUP VIII AND A PHOSPHINITE LIGAND, AND A METHOD FOR HYDROFORMYLATION | BASF AG (DE) | 2005-04-06 | — | — | EP | disclosed |
| US-20030149267-A1 | Valeraldehyde and process for its preparation | CELANESE GMBH | 2003-08-07 | — | — | US | disclosed |
| US-6566521-B2 | Bidentate phosphine ligands; for preparing linear aldehydes by hydroformylating internal olefins using said phosphine ligands | CELANESE GMBH (DE) | 2003-05-20 | — | — | US | disclosed |
| EP-0982314-B1 | Valeraldehyde and process for its preparation | CELANESE CHEM EUROPE GMBH (DE) | 2003-05-07 | — | — | EP | disclosed |
| US-6486359-B1 | Catalyst comprising a complex of a metal of subgroup viii based on a phosphinite ligand, and a method for hydroformylation | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-26 | — | — | US | disclosed |
| US-20020065434-A1 | Valeraldehyde and process for its preparation | GEISSLER HOLGER (DE) | 2002-05-30 | — | — | US | disclosed |
| US-6342605-B1 | BIDENTATE PHOSPHINE LIGAND USED IN PREPARATION OF LINEAR ALDEHYDE BY HYDROFORMYLATING INTERNAL OLEFIN WITH CARBON MONOXIDE AND HYDROGEN | CELANESE GMBH (DE) | 2002-01-29 | — | — | US | disclosed |
| JP-2000072787-A | VALERALDEHYDE AND ITS PRODUCTION | SELANESE GMBH | 2000-03-07 | — | — | JP | disclosed |
| EP-0982314-A2 | Valeraldehyde and process for its preparation | Celanese Chemicals Europe GmbH (DE) | 2000-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149267-A1 | Valeraldehyde and process for its preparation | VARS1, ALDH1A1, ALDH3A1 | GABBR2 1552/4885GABBR1 1073/4885HIF1A 951/4885 |
| US-10224493-B2 | Boron-containing compounds | BRI3BP, BTD, BICRA | GABBR2 384/4885GABBR1 661/4885HIF1A 3805/4885 |
| US-20190211040-A1 | P-CHIRAL PHOSPHINE LIGANDS AND USE THEREOF FOR ASYMMETRIC SYNTHESIS | PLCD1, PLCB3, PHOSPHO1 | GABBR2 2879/4885GABBR1 2229/4885HIF1A 1286/4885 |
| US-10919921-B2 | P-chiral phosphine ligands and use thereof for asymmetric synthesis | PLCD1, PLCB3, PHOSPHO1 | GABBR2 2879/4885GABBR1 2229/4885HIF1A 1286/4885 |
| US-20020065434-A1 | Valeraldehyde and process for its preparation | VARS1, ALDH1A1, ALDH3A1 | GABBR2 1552/4885GABBR1 1073/4885HIF1A 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.